This is a non-binding cooperation agreement with no committed minimums or financial projections — largely a story stock development. Monitor for specific revenue guidance or an executed joint venture. Given the $12M market cap and history of low stock movement on similar announcements, expect limited near-term impact.
Price Chart
Executive Summary
Instinct Bio announced a cooperation agreement with PT Parva Candela to jointly develop Indonesia's cosmetics and personal care market, leveraging PARVA's local manufacturing and distribution network. The deal includes a 50% profit share plus revenue from ingredient supply, royalties, and brand licensing, but provides no committed minimums or near-term financial guidance.
Key Facts
- Cooperation agreement with PT Parva Candela for joint development of Indonesia's cosmetics market under 'Made in Indonesia, Powered by Japanese Formulation Expertise' concept.
- PARVA is affiliated with DELTASPA Group, a spa chain operating approximately 25 locations across Indonesia.
- Instinct Bio retains ownership of proprietary ingredients and formulations, granting limited licenses.
- Revenue streams include a 50% profit share, proprietary ingredient supply, formulation royalties, and brand licensing fees for GENRÊVER and HAKUA brands.
- Indonesia's beauty and personal care market estimated at approximately US$10.5 billion in 2026, growing approximately 5.5% annually.
- This is the third component of Instinct Bio's organic growth strategy, following the GENRÊVER CLINIC announcement (July 29, 2026) and the collaboration with Invitrx Therapeutics, Inc. (July 30, 2026).
- The company was formerly known as Relativity Holdings Inc., changed name on June 9, 2025.
Financial Impact
No financial figures disclosed in the filing; revenue and profit-sharing terms are unquantified.
Risk Factors
- No committed minimum revenue, royalties, or timeline specified — execution risk is high.
- Forward-looking statements contain no assurance that the collaboration will achieve any particular commercial result.
- Micro-cap cosmetics company with $12M market cap — limited liquidity and high volatility.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (BIOT) — Batch item 1 | 0001104659-26-093174 |
| Document: tm2622710d1_ex99-1.htm | 0001104659-26-093174 |
| Document: 0001104659-26-093174-index-headers.html | 0001104659-26-093174 |
| Document: 0001104659-26-093174-index.html | 0001104659-26-093174 |
| Document: 0001104659-26-093174.txt | 0001104659-26-093174 |
| 6-K Filing (BIOT) — Batch item 6 | 0001104659-26-093174 |
| Document: tm2622710d1_ex99-1.htm | 0001104659-26-093174 |
| Document: 0001104659-26-093174-index-headers.html | 0001104659-26-093174 |
| Document: 0001104659-26-093174-index.html | 0001104659-26-093174 |
| Document: 0001104659-26-093174.txt | 0001104659-26-093174 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 6-K | $0.2300 | awaiting T+20 | — | $0.2007 (−12.74%) |
Oct 1, 2026 26d ago | 6-K | $0.3533 | awaiting T+20 | — | $0.2007 (−43.19%) |
Sep 15, 2026 6w ago | 6-K | $0.3700 $0.3602 | ▲ +2.65% | ▲ +5.63% | $0.2007 (+45.76%) |
Aug 10, 2026 11w ago | 6-K | $0.4019 $0.3863 | ▼ −3.88% | ▼ −2.97% | $0.2007 (−50.06%) |
Jul 30, 2026 12w ago | 6-K | $0.4990 $0.4470 | ▼ −10.42% | ▼ −14.39% | $0.2007 (−59.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers